Prognostic value of poorly differentiated clusters in the primary tumor in patients undergoing hepatectomy for colorectal liver metastasis

Surgery (United States)

Volumn 157, Issue 5, 2015, Pages 899-908

  Ueno, Hideki ^a   Konishi, Tsuyoshi ^b   Ishikawa, Yuichi ^b   Shimazaki, Hideyuki ^a   Ueno, Masashi ^b   Aosasa, Suefumi ^a   Saiura, Akio ^b   Hase, Kazuo ^a   Yamamoto, Junji ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARMOFUR; DOXIFLURIDINE; FLUOROURACIL; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; UFT;

ADJUVANT CHEMOTHERAPY; ADULT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; COLORECTAL LIVER METASTASIS; CONFERENCE PAPER; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PRIMARY TUMOR; PRIORITY JOURNAL; RECURRENCE RISK; SURVIVAL PREDICTION; TUMOR DIFFERENTIATION; AGED; CANCER GRADING; COLON; COLORECTAL NEOPLASMS; JAPAN; LIVER NEOPLASMS; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PROGNOSIS; RECTUM; RETROSPECTIVE STUDY; SECONDARY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; COLON; COLORECTAL NEOPLASMS; FEMALE; HEPATECTOMY; HUMANS; JAPAN; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RECTUM; RETROSPECTIVE STUDIES;

EID: 84929045018     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2014.12.025     Document Type: Conference Paper

References (38)

1. R. Adam, P. Bhangui, G. Poston, D. Mirza, G. Nuzzo, and E. Barroso Is perioperative chemotherapy useful for solitary, metachronous, colorectal liver metastases? Ann Surg 252 2010 774 787
2. D. Gomez, and I.C. Cameron Prognostic scores for colorectal liver metastasis: clinically important or an academic exercise? HPB (Oxford) 12 2010 227 238
3. B. Nordlinger, M. Guiguet, J.-C. Vaillant, P. Balladur, K. Boudjema, and P. Bachellier Surgical resection of colorectal carcinoma metastases to the liver. a prognostic scoring system to improve case selection, based on 1568 patients Cancer 77 1996 1254 1262
4. Y. Fong, J. Fortner, R.L. Sun, M.F. Brennan, and L.H. Blumgart Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer. Analysis of 1001 consecutive cases Ann Surg 230 1999 309 321
5. M. Minagawa, J. Yamamoto, T. Kosuge, Y. Matsuyama, S. Miyagawa, and M. Makuuchi Simplified staging system for predicting the prognosis of patients with resectable liver metastasis Arch Surg 142 2007 269 276
6. Japanese Society for Cancer of the Colon and Rectum Japanese classification of colorectal carcinoma (second English edition) 2009 Kanehara & Co., Ltd. Tokyo
7. K. Hase, C. Shatney, D. Johnson, M. Trollope, and M. Vierra Prognostic value of tumor "budding" in patients with colorectal cancer Dis Colon Rectum 36 1993 627 635
8. H. Ueno, J. Murphy, J.R. Jass, H. Mochizuki, and I.C. Talbot Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer Histopathology 40 2002 127 132
9. H.J. Schmoll, E. Van Cutsem, A. Stein, V. Valentini, B. Glimelius, and K. Haustermans ESMO consensus guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making Ann Oncol 23 2012 2479 2516
10. M.S. Roh, J.I. Lee, and P.J. Choi Tumor budding as a useful prognostic marker in esophageal squamous cell carcinoma Dis Esophagus 17 2004 333 337
11. R. Masuda, H. Kijima, N. Imamura, N. Aruga, Y. Nakamura, and D. Masuda Tumor budding is a significant indicator of poor prognosis in lung squamous cell carcinoma patients Mol Med Rep 6 2012 937 943
12. E. Karamitopoulou, I. Zlobec, D. Born, A. Kondi-Pafiti, P. Lykoudis, and A. Mellou Tumour budding is a strong and independent prognostic factor in pancreatic cancer Eur J Cancer 49 2013 1032 1039
13. H. Ueno, H. Shimazaki, E. Shinto, Y. Hashiguchi, K. Nakanishi, and K. Maekawa New criteria for histologic grading of colorectal cancer Am J Surg Pathol 36 2012 193 201
14. V. Barresi, L.R. Bonetti, G. Branca, C.D. Gregorio, M.P. de Leon, and G. Tuccari Colorectal carcinoma grading by quantifying poorly differentiated cell clusters is more reproducible and provides more robust prognostic information than conventional grading Virchows Arch 461 2012 621 628
15. H. Ueno, K. Hase, Y. Hashiguchi, H. Shimazaki, M. Tanaka, and O. Miyake Site-specific tumor grading system in colorectal cancer: multicenter pathological review of the value of quantifying poorly differentiated clusters Am J Surg Pathol 38 2014 197 204
16. H. Ueno, H. Mochizuki, K. Hatsuse, K. Hase, and T. Yamamoto Indicators for treatment strategies of colorectal liver metastases Ann Surg 231 2000 59 66
17. H. Ueno, H. Mochizuki, Y. Hashiguchi, K. Hatsuse, H. Fujimoto, and K. Hase Predictors of extrahepatic recurrence after resection of colorectal liver metastases Br J Surg 53 2004 581 586
18. H. Ueno, A.B. Price, K.H. Wilkinson, J.R. Jass, H. Mochizuki, and I.C. Talbot A new prognostic staging system for rectal cancer Ann Surg 240 2004 832 839
19. H. Ueno, H. Mochizuki, Y. Hashiguchi, H. Shimazaki, S. Aida, and K. Hase Risk factors for an adverse outcome in early invasive colorectal carcinoma Gastroenterology 127 2004 385 394
20. T. Watanabe, M. Itabashi, Y. Shimada, S. Tanaka, Y. Ito, and Y. Ajioka Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer Int J Clin Oncol 17 2009 1 29
21. L. Spelt, B. Andersson, J. Nilsson, and R. Andersson Prognostic models for outcome following liver resection for colorectal cancer metastasis: a systematic review Eur J Surg Oncol 38 2012 16 24
22. T. Beppu, Y. Sakamoto, K. Hasegawa, G. Honda, K. Tanaka, and Y. Kotera A nomogram predicting disease-free survival in patients with colorectal liver metastases treated with hepatic resection: multicenter data collection as a Project Study for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery J Hepatobiliary Pancreat Sci 19 2012 72 84
23. C. Are, M. Gonen, K. Zazzali, R.P. DeMatteo, W.R. Jarnagin, and Y. Fong The impact of margins on outcome after hepatic resection for colorectal metastasis Ann Surg 246 2007 295 300
24. D. Gomez, G. Morris-Stiff, G.J. Toogood, J.P.A. Lodge, and K.R. Prasad Interaction of tumour biology and tumour burden in determining outcome after hepatic resection for colorectal metastases HPB (Oxford) 12 2010 84 93
25. R. Adam, R.J. de Haas, D.A. Wicherts, E. Vibert, C. Salloum, and D. Azoulay Concomitant extrahepatic disease in patients with colorectal liver metastases. When is there a place for surgery? Ann Surg 253 2011 349 359
26. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology-colon cancer (version 2. 2015) [cited 2015 Feb 17]. Available from: http://www.nccn.org/professionals/physician-gls/pdf/colon.pdf.
27. T. Aoki, N. Umekita, S. Tanaka, K. Noda, M. Warabi, and M. Kiamura Prognostic value of concomitant resection of extrahepatic disease in patients with liver metastases of colorectal origin Surgery 143 2008 706 714
28. G.G. Van den Eynden, N.C. Bird, A.W. Majeed, S. Van Laere, L.Y. Dirix, and P.B. Vermeulen The histological growth pattern of colorectal cancer liver metastases has prognostic value Clin Exp Metastasis 29 2012 541 549
29. B. Ohlsson, U. Stenram, and K.G. Tranberg Resection of colorectal liver metastases: 25-year experience World J Surg 22 1998 268 277
30. M. Koike, K. Yasui, A. Torii, and S. Kodama Prognostic significance of entrapped liver cells in hepatic metastases from colorectal cancer Ann Surg 232 2000 653 657
31. J.R. Jass, M. Barker, L. Fraser, M.D. Walsh, V.L.J. Whitehall, and B. Gabtielli APC mutation and tumour budding in colorectal cancer J Clin Pathol 56 2003 69 73
32. E. Shinto, K. Baker, H. Tsuda, H. Mochizuki, H. Ueno, and O. Matsubara Tumor buds show reduced expression of laminin-5 gamma 2 chain in DNA mismatch repair deficient colorectal cancer Dis Colon Rectum 49 2006 1193 1202
33. J. García-Solano, P. Conesa-Zamora, J. Trujillo-Santos, M.J. Mäkinen, and M. Pérez-Guillermo Tumour-budding and other prognostic pathological features at invasive margins in serrated colorectal adenocarcinoma: a comparative study with conventional carcinoma Histopathology 59 2011 1046 1056
34. C. Du, W. Xue, J. Li, Y. Cai, and J. Gu Morphology and prognostic value of tumor budding in rectal cancer after neoadjuvant radiotherapy Hum Pathol 43 2012 1061 1067
35. M. Brown, K. Sillah, E.A. Griffiths, R. Swindell, C.M. West, and R.D. Page Tumour budding and a low host inflammatory response are associated with a poor prognosis in oesophageal and gastro-oesophageal junction cancers Histopathology 56 2010 893 899
36. F. Prall Tumour budding in colorectal carcinoma Histopathology 50 2007 151 162
37. J.S. Vermaat, I.J. Nijman, M.J. Koudijs, F.L. Gerritse, S. Scherer, and M. Mokry Primary colorectal cancers and their subsequent hepatic metastases are genetically different: implications for selection of patients for targeted treatment Clin Cancer Res 18 2011 688 699
38. B. Nordlinger, H. Sorbye, B. Glimelius, G.J. Poston, P.M. Schlag, and P. Rougier Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial Lancet 371 2008 1007 1016